Seth Klarman Akebia Therapeutics, Inc.

Avg closing price

Price range

Sold 14.4% shares (-2.53 Million shares) Q2 2020

$10.35

$6.67 - $13.58

New holding (+24.5 Million shares) Q4 2018

$7.83

$5.39 - $9.15

Sold -15 Million shares Q3 2020

$8.78

$2.39 - $13.08

Sold 10.4% shares (-2.04 Million shares) Q1 2020

$7.78

$4.10 - $10.24

Sold 20.0% shares (-4.9 Million shares) Q4 2019

$4.75

$3.16 - $6.73